Amyris is pleased to announce that it has been awarded an agreement through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-C) for up to $12.3 million to advance innovative pharmaceutical manufacturing in the United States. Amyris aims to develop up to three small molecule drugs over the next two years – all of which are on the FDA drug shortage list. For more information, please see our press release: https://lnkd.in/d4VKeGh7
关于我们
Amyris is a vertically integrated, synthetic biology company that creates sustainable, market-ready ingredients utilizing proprietary advanced precision fermentation technology and world-class platforms. Leveraging two decades of experience, Amyris collaborates with companies to co-create innovative ingredients at unprecedented speed and scale. This enables partners to deliver products with differentiated performance that meet sustainability and economic objectives. Its renewable and traceable ingredients are included in over 20,000 products from the world’s top brands, reaching more than 300 million consumers. For more information, please visit https://www.amyris.com.
- 网站
-
https://www.amyris.com
Amyris的外部链接
- 所属行业
- 生物技术研究
- 规模
- 501-1,000 人
- 总部
- Emeryville，CA
- 类型
- 私人持股
- 创立
- 2003
- 领域
- synthetic biology、specialty renewable chemicals、biotech、clean beauty、sweetener、CBD、natural ingredients、sustainability、hand sanitizer、adjuvants、vaccines、fermentation、Reb M、squalane、squalene、biosilica、fragrances、flavors、health、wellness和consumers
地点
Amyris员工
动态
-
Amyris is pleased to announce the appointment of Kathy Fortmann as our Chief Executive Officer and a member of our Board, effective immediately. We are fortunate to have her join at this pivotal moment, following the effectiveness of Amyris' reorganization announced today. With a background in chemical engineering, Kathy brings almost 35 years of global business experience across a range of industries including specialty chemicals and ingredients.?For more on her background, please see our press release: https://lnkd.in/dVBa7Q2Q.
Press Release - Amyris
amyris.com